Article Details
Retrieved on: 2024-01-16 21:42:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
16, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of ...
Article found on: ir.allogene.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here